<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20051210/bs_nm/merck_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/nm/20051210/2005_12_09t152908_450x266_us_merck.jpg?x=130&y =76&sig=t1zto.d8VzQgvWP5rxihrA--" align="left" height="76" width="130" alt="File photo shows bottles of the prescription arthritis and pain medication VIOXX September 30, 2004. As the first federal jury deliberates whether Merck and Co.'s painkiller Vioxx contributed to a Florida man's death, investors on Friday digested new claims that the battered company withheld key data about the drug's dangers. (Mike Segar/Reuters)" border="0" /></a>Reuters - A U.S. judge asked the jury in the
first federal lawsuit against Merck & Co's Vioxx to keep
deliberating on Saturday after the panel said it could not
reach a verdict on whether the drug contributed to the death of
a Florida man.</p><br clear=all>
View the entire article:
Vioxx jury to continue deliberations (Reuters)
Vioxx jury to continue deliberations (Reuters)
Linear Mode
